This is a StreetInsider.com Premium Only Page

Immunogen (IMGN) – Hot FDA News

May 3, 2023 07:09 AM Immunogen (IMGN) Climbs 89% After Study Shows OS Benefit in Phase 3 MIRASOL Trial in Patients with FRα-Positive Platinum-Resistant Ovarian Cancer

Nov 14, 2022 04:30 PM Immunogen (IMGN) Announces FDA Accelerated Approval of ELAHERE for Treatment of Platinum-Resistant Ovarian Cancer

Feb 15, 2022 06:34 AM

Nov 30, 2021 06:30 AM

Oct 5, 2020 06:35 AM

May 15, 2019 06:33 AM

Mar 1, 2019 06:32 AM

Dec 11, 2017 06:27 AM

Oct 16, 2017 08:03 AM

Dec 19, 2014 08:01 AM